These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37157213)

  • 1. Case Report: Novel Pathogenic Variant Detected in Two Siblings with Type 1 Gaucher Disease.
    Dursun H ; Metli K ; Bayram F
    Endocr Metab Immune Disord Drug Targets; 2023 May; ():. PubMed ID: 37157213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare
    d'Avila Paskulin L; Starosta RT; Zizemer VS; Basgalupp S; Bertholdo D; Vairo FPE; Siebert M; Michelin-Tirelli K; Schwartz IVD
    Mol Genet Metab Rep; 2019 Dec; 21():100544. PubMed ID: 31799121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation.
    Sheth J; Bhavsar R; Mistri M; Pancholi D; Bavdekar A; Dalal A; Ranganath P; Girisha KM; Shukla A; Phadke S; Puri R; Panigrahi I; Kaur A; Muranjan M; Goyal M; Ramadevi R; Shah R; Nampoothiri S; Danda S; Datar C; Kapoor S; Bhatwadekar S; Sheth F
    BMC Med Genet; 2019 Feb; 20(1):31. PubMed ID: 30764785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gaucher disease: A review].
    Nguyen Y; Stirnemann J; Belmatoug N
    Rev Med Interne; 2019 May; 40(5):313-322. PubMed ID: 30638965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene.
    Lepe-Balsalobre E; Santotoribio JD; Nuñez-Vazquez R; García-Morillo S; Jiménez-Arriscado P; Hernández-Arévalo P; Delarosa-Rodríguez R; Guerrero JM; Macher HC
    Clin Chem Lab Med; 2020 Jun; 58(12):2017-2024. PubMed ID: 32589593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
    Yildiz Y; Hoffmann P; Vom Dahl S; Breiden B; Sandhoff R; Niederau C; Horwitz M; Karlsson S; Filocamo M; Elstein D; Beck M; Sandhoff K; Mengel E; Gonzalez MC; Nöthen MM; Sidransky E; Zimran A; Mattheisen M
    Orphanet J Rare Dis; 2013 Sep; 8():151. PubMed ID: 24070122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebrosidase and its relevance to Parkinson disease.
    Do J; McKinney C; Sharma P; Sidransky E
    Mol Neurodegener; 2019 Aug; 14(1):36. PubMed ID: 31464647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin.
    Kinghorn KJ; Grönke S; Castillo-Quan JI; Woodling NS; Li L; Sirka E; Gegg M; Mills K; Hardy J; Bjedov I; Partridge L
    J Neurosci; 2016 Nov; 36(46):11654-11670. PubMed ID: 27852774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
    Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
    Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanism of Gaucher disease caused by compound heterozygous mutations in
    Liu Q; Shen Z; Pan H; Ma S; Xiong F; He F
    Front Pediatr; 2023; 11():1092645. PubMed ID: 36776904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of neurological manifestations and genotype-phenotype correlation in Indian children with Gaucher disease.
    Venkatachari M; Chakraborty S; Correa ARE; Mishra P; Kocchar KP; Kabra M; Chakrabarty B; Kalaivani M; Sapra S; Mishra P; Gulati S; Gupta N
    Am J Med Genet A; 2023 Apr; 191(4):1038-1043. PubMed ID: 36637080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.
    Huang Y; Jia X; Tang C; Liu S; Sheng H; Zhao X; Zeng C; Liu L
    Clin Chim Acta; 2020 Jul; 506():22-27. PubMed ID: 32165122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for potential undiagnosed Gaucher disease patients: Utilisation of the Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS) in conjunction with electronic health record data, tissue specimens, and small nucleotide polymorphism (SNP) genotype data available in Finnish biobanks.
    Pehrsson M; Heikkinen H; Wartiovaara-Kautto U; Mäntylahti S; Bäckström P; Lassenius MI; Uusi-Rauva K; Carpén O; Elomaa K
    Mol Genet Metab Rep; 2022 Dec; 33():100911. PubMed ID: 36092251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two siblings with Gaucher type 3c: different clinical presentations.
    Karakoyun M; Canda E; Kiran Tasci E; Dogan E; Coker M; Aydogdu S
    J Pediatr Endocrinol Metab; 2019 May; 32(5):533-536. PubMed ID: 31026225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and Phenotypic Analysis of the Novel Gaucher Disease Mouse Model With the Partially Humanized
    Guo JN; Guan M; Jiang N; Li N; Li YJ; Zhang J; Ma D
    Front Genet; 2022; 13():892457. PubMed ID: 35711931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The D409H variant in GBA1: Challenges in predicting the Gaucher phenotype in the newborn screening era.
    Gleason AM; D'Souza A; Ryan E; Grochowsky AR; Carter CR; Goker-Alpan O; Lopez G; Tayebi N; Sidransky E
    Am J Med Genet A; 2023 Jul; 191(7):1783-1791. PubMed ID: 37042183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound heterozygous p.L483P and p.S310G mutations in GBA1 cause type 1 adult Gaucher disease: A case report.
    Wen XL; Wang YZ; Zhang XL; Tu JQ; Zhang ZJ; Liu XX; Lu HY; Hao GP; Wang XH; Yang LH; Zhang RJ
    World J Clin Cases; 2022 Dec; 10(36):13426-13434. PubMed ID: 36683633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational study to investigate the relationship between plasma glucosylsphingosine (lyso-Gb1) concentration and treatment outcomes of patients with Gaucher disease in Japan.
    Ida H; Watanabe Y; Sagara R; Inoue Y; Fernandez J
    Orphanet J Rare Dis; 2022 Nov; 17(1):401. PubMed ID: 36329499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
    Stirnemann J; Belmatoug N; Camou F; Serratrice C; Froissart R; Caillaud C; Levade T; Astudillo L; Serratrice J; Brassier A; Rose C; Billette de Villemeur T; Berger MG
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218669
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.